Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight

The metagenomics sequencing market is mainly fueled by the combined influence of several major factors. The growing prevalence of infectious diseases, including emerging and re-emerging pathogens, has heightened the demand for rapid and unbiased diagnostic solutions that can detect a broad spectrum of microorganisms without requiring prior assumptions. Simultaneously, ongoing advancements in next-generation sequencing (NGS) technologies, such as enhanced accuracy, faster turnaround times, and lower costs, have made metagenomic methods increasingly accessible and scalable for both clinical and research applications.

New York, USA, April 29, 2026 (GLOBE NEWSWIRE) -- Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight

The metagenomics sequencing market is mainly fueled by the combined influence of several major factors. The growing prevalence of infectious diseases, including emerging and re-emerging pathogens, has heightened the demand for rapid and unbiased diagnostic solutions that can detect a broad spectrum of microorganisms without requiring prior assumptions. Simultaneously, ongoing advancements in next-generation sequencing (NGS) technologies, such as enhanced accuracy, faster turnaround times, and lower costs, have made metagenomic methods increasingly accessible and scalable for both clinical and research applications.

DelveInsight’s Metagenomics Sequencing Market Insights report provides the current and forecast market analysis, individual leading metagenomics sequencing companies’ market shares, challenges, metagenomics sequencing market drivers, barriers, trends, and key metagenomics sequencing companies in the market.

Metagenomics Sequencing Market Summary

• 2025 Metagenomics Sequencing Market Size: USD 2.5 Billion
• 2034 Projected Metagenomics Sequencing Market Size: USD 7.5 Billion
• Metagenomics Sequencing Market Growth Rate (2026-2034): ~13% 
• Largest Metagenomics Sequencing Market: North America
• Largest Component Segment: Reagents and Consumables Category
• Key Companies in the Metagenomics Sequencing Market: F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Oxford Nanopore Technologies, Pacific Biosciences, BGI Genomics, QIAGEN, PerkinElmer, Promega Corporation, Takara Bio, Eurofins Scientific, Novogene, Macrogen, GENEWIZ, MR DNA, SeqMatic, and others

To read more about the latest highlights related to the metagenomics sequencing market, get a snapshot of the key highlights @  https://www.delveinsight.com/sample-request/metagenomic-sequencing-market

Key Factors Contributing to the Rise in Growth of the Metagenomics Sequencing Market

• Declining Cost of Next-Generation Sequencing (NGS): Continuous reductions in sequencing costs have made metagenomics more affordable for research laboratories, hospitals, and biotech companies. Lower costs are enabling wider adoption across routine and large-scale applications.
• Rising Burden of Infectious Diseases: The increasing prevalence of emerging and re-emerging infectious diseases has accelerated demand for rapid, unbiased diagnostic methods. Metagenomic sequencing can identify bacteria, viruses, fungi, and parasites directly from clinical samples without prior assumptions.
• Growing Interest in Microbiome Research: Expanding research on the human gut, skin, oral, and environmental microbiomes is significantly fueling demand. Scientists are increasingly studying microbial communities to understand their role in immunity, metabolism, cancer, and chronic diseases.
• Advancements in Sequencing Platforms: Innovations such as high-throughput sequencers, portable sequencers, long-read technologies, and automated workflows have improved speed, sensitivity, and accuracy, making metagenomic studies more practical and scalable.
• Expansion in Clinical Diagnostics: Hospitals and diagnostic labs are increasingly adopting metagenomic sequencing for sepsis, meningitis, antimicrobial resistance detection, and unknown pathogen identification, especially when conventional culture methods fail.
• Increasing Government & Private Funding: Public health agencies, academic institutes, and private investors are supporting genome mapping programs, pathogen surveillance projects, and microbiome research initiatives, driving market expansion.
• Rising Use in Agriculture & Environmental Monitoring: Metagenomics is increasingly used in soil health analysis, crop improvement, livestock microbiome studies, wastewater surveillance, biodiversity monitoring, and pollution assessment.
• Improved Bioinformatics & Data Analytics Tools: Advances in AI-powered analytics, cloud computing, and faster bioinformatics pipelines have simplified the interpretation of complex sequencing datasets, making metagenomics more accessible to end users.
• Drug Discovery and Precision Medicine Applications: Pharmaceutical companies are leveraging metagenomic data for biomarker discovery, microbiome-based therapeutics, and personalized treatment strategies, creating new commercial opportunities.

Get a sneak peek at the metagenomics sequencing market dynamics @ Metagenomics Sequencing Market Trends

Regional Metagenomics Sequencing Market Insights

North America

• North America held the largest share of the metagenomics sequencing market in 2025, accounting for 41% of the global market. 
• This dominance is attributed to the region’s well-established healthcare infrastructure, substantial research investments, ongoing technological advancements, and early adoption of clinical applications, positioning it as a global frontrunner in the sector.
• The region’s strong market position is further supported by the presence of leading companies such as Illumina, Thermo Fisher Scientific, and Roche, all of which continue to invest heavily in next-generation sequencing platforms and advanced reagents, driving wider market adoption.
• Moreover, robust government backing through organizations like the National Institutes of Health and large-scale genomics programs has significantly boosted funding for microbiome studies, infectious disease monitoring, and precision medicine initiatives, further increasing demand for metagenomic sequencing solutions.

Europe

• In Europe, the metagenomic sequencing market is experiencing strong growth due to the rising adoption of advanced genomic technologies, increasing government support for microbiome and infectious disease research, and the region’s robust healthcare and research infrastructure. 
• Countries such as Germany, the United Kingdom, and France are making significant investments in precision medicine programs and large-scale genomics initiatives, which are driving the application of metagenomic sequencing in both clinical diagnostics and research. 
• Furthermore, favorable regulatory policies and strategic partnerships between academic institutions and biotechnology companies are encouraging innovation and promoting wider adoption of sequencing technologies.

Asia-Pacific

• The Asia Pacific region is becoming a major growth engine for the metagenomic sequencing market, supported by the rapid development of healthcare infrastructure, rising government funding for genomics research, and an increasing prevalence of infectious diseases. 
• Nations such as China, India, and Japan are actively advancing precision medicine programs and large-scale genomic initiatives, which are speeding up the adoption of cutting-edge sequencing technologies.
• Moreover, the expanding footprint of regional biotechnology firms, growing awareness regarding early disease diagnosis, and better accessibility to next-generation sequencing platforms are further supporting market growth. 
• The region’s emphasis on enhancing disease surveillance capabilities and controlling outbreaks is also increasing the need for fast and comprehensive metagenomic sequencing solutions, positioning the Asia Pacific as an important contributor to global market growth.

To know more about why North America is leading the market growth in the metagenomics sequencing market, get a snapshot of the Metagenomics Sequencing Market Share

Recent Developmental Activities in the Metagenomics Sequencing Market

• In November 2025, Oxford Nanopore Technologies released a rapid metagenomic sequencing protocol using the SQK-RPB114.24 kit.
• In February 2025, Ginkgo Bioworks announced a collaboration with the European Health and Digital Executive Agency as a contracting authority under a joint tender of €24 million.
• In January 2025, the government of India launched the Indian Genomic Data Set and GenomeIndia Project, providing access to over 10,000 whole genome sequences to support research, drug development, and personalized healthcare.
• In May 2024, QIAGEN announced the launch of its QIAseq Multimodal DNA/RNA Library Kit, which enabled the simultaneous preparation of DNA and RNA libraries from a single sample for next-generation sequencing applications such as whole genome and transcriptome sequencing.

What is Metagenomics Sequencing?

Metagenomic sequencing is an advanced genomic technique used to analyze the collective genetic material of all microorganisms present in a sample, without the need to isolate or culture individual species in the laboratory. It enables researchers to study complex microbial communities, including bacteria, viruses, fungi, and archaea, directly from environments such as soil, water, the human gut, blood, or respiratory samples. By sequencing and identifying DNA or RNA fragments from these mixed populations, metagenomics provides valuable insights into microbial diversity, abundance, functional genes, and interactions within an ecosystem. This technology is widely used in clinical diagnostics, infectious disease detection, microbiome research, environmental monitoring, agriculture, and biotechnology, as it can detect known and novel pathogens while offering a comprehensive understanding of microbial ecosystems.

Metagenomics Sequencing Market Assessment

• Metagenomics Sequencing Market Segmentation
  • Metagenomics Sequencing Market Segmentation By Component: Product {Instruments and Reagents & Kits} and Services, Technology (Shotgun Metagenomic Sequencing, 16S rRNA Sequencing, Whole Genome Sequencing (WGS) & De Novo Assembly, and Metatranscriptomics
  • Metagenomics Sequencing Market Segmentation By Application: Drug Discovery and Development, Clinical Diagnostics, and Others
  • Metagenomics Sequencing Market Segmentation By End User: Pharmaceutical & Biotechnology Companies, Research Laboratories, and Others
  • Metagenomics Sequencing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the metagenomics sequencing market are set to emerge as the trendsetter explore @ Metagenomics Sequencing Market Analysis

Table of Contents 

Interested in knowing the metagenomics sequencing market share by 2034? Click to get a snapshot of the Metagenomics Sequencing Market Size 

Related Reports

Genome Editing Market

Genome Editing Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key genome editing companies, including CRISPR Therapeutics, Thermo Fisher Scientific Inc., Editas Medicine, Revvity Discovery Limited, Biocompare, CrisprBits, GenAhead Bio Inc., Merck KGaA, GenScript, Agilent Technologies, Inc., Lonza, Tecan Trading AG, Sangamo Therapeutics, Precision BioSciences, Cellectis S.A., Regeneron Pharmaceuticals Inc., AMSBIO, Creative Biogene, Synthego, Takara Bio Inc., and others.

Genetic Testing Market

Genetic Testing Market Insights, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key genetic testing companies, including Illumina, Myriad Genetics, 23andMe, and others.

Genomics Market

Genomics Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key genomics companies, including Thermo Fisher Scientific, Inc., Agilent Technologies, BGI, Bio-Rad Laboratories, Inc., Danaher., F. Hoffmann-La Roche Ltd, Illumina, Inc., Oxford Nanopore Technologies plc., PacBio., QIAGEN, Quest Diagnostics, Myriad Genetics, Inc., Color Health, Inc., Veritas., CD Genomics, GenomSys, IntegraGen, NimaGen B.V., NRGene, Abbott, and others.

DNA Sequencing Market

DNA Sequencing Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key DNA sequencing companies, including Agilent Technologies Inc., Biorad Laboratories Ltd, Danaher Corporation, F. Hoffmann-La Roche Ltd, Illumina Inc, PerkinElmer Inc, Merck & Co., Inc, QIAGEN, Thermo Fisher Scientific, PacBio, Macrogen Inc, Oxford Nanopore Technologies plc, CD Genomics, Takara Bio Inc, Promega Corporation, BGI, 10x Genomics, Eurofins Genomics, GENEWIZ (Azenta Life Sciences), and others.

Next-generation Sequencing Market

Next-generation Sequencing Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key next-generation sequencing companies, including Agilent Technologies, Inc., Illumina Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, QIAGEN, Thermo Fisher Scientific, PerkinElmer Inc., MedGenome, BGI, Pacific Biosciences, GENEWIZ, Oxford Nanopore Technologies plc., Psomagen, Inc., 10x Genomics, Takara Bio Inc., Zymo Research Corporation, NuGEN Technologies, Inc. (Tecan Trading AG), Vela Diagnostics, CD Genomics, HTG Molecular Diagnostics, Inc., and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Us

Shruti Thakur 

info@delveinsight.com 

+14699457679

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.